4135-85-7 Usage
Uses
Used in Pharmaceutical Industry:
(24E)-8-[(dimethylamino)methyl]-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate is used as a potential pharmaceutical agent for [specific medical condition or treatment] due to its unique molecular structure and functional groups that may exhibit specific biological activities.
Used in Chemical Research:
In the field of chemical research, (24E)-8-[(dimethylamino)methyl]-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate serves as a subject of study for understanding the synthesis, properties, and potential applications of complex organic compounds with diverse functional groups and ring systems.
Check Digit Verification of cas no
The CAS Registry Mumber 4135-85-7 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,1,3 and 5 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 4135-85:
(6*4)+(5*1)+(4*3)+(3*5)+(2*8)+(1*5)=77
77 % 10 = 7
So 4135-85-7 is a valid CAS Registry Number.
4135-85-7Relevant academic research and scientific papers
3-N-substituted aminomethyl derivatives of rifamycin SV. A convenient method of synthesis, cyclization of certain derivatives, and anticellular and antiviral activities of several derivatives
McCarthy,Moore,Wysong,Aldrich
, p. 1272 - 1276 (2007/10/21)
A new synthesis of Mannich bases of rifamycin SV using the Borch procedure with rifaldehyde is described. This new synthesis offers two advantages over the previously published method. It provides a route to monoalkyl-aminomethylrifamycins (1e-h) and to unsubstituted aminomethylrifamycins that were not accessible by the old procedure. The new method also offers a preparative route to Mannich bases 1a and 1b which were needed in multigram quantities for biological testing. In addition, the cyclization of certain of the monoalkylaminomethylrifamycins to the novel N,15 didehydro 15 deoxo 3,15 epi[methano(alkylimino)]rifamycin SV derivatives is described. The anticellular and antiviral effects of representatives of both series of compounds against cultured mouse cells and murine oncornavirus are discussed.
